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Counting Antigen-Specific CD8 T Cells:
A Reevaluation of Bystander Activation
during Viral Infection
repertoire, there has been considerable interest in de-
termining how much of this expansion represents virus-
specific CD8 T cells and how much of it is due to activa-
tion of T cells not specific to the immunizing antigen
(Nahill and Welsh, 1993; Razvi et al., 1995; Selin et al.,
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ulation of cell division by cross-reactive antigens, or
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Limiting dilution analysis (LDA) to quantitate virus-spe-Viral infections induce extensive T cell proliferation in
cific cytotoxic T lymphocytes (CTL) has shown that onlyvivo, but the specificity of the majority of the re-
a small fraction (1%±5% at most) of the activated CD8sponding T cells has not been defined. To address this
T cells are antigen specific at the peak of the primaryissue we used tetramers of MHC class I molecules
response (Doherty et al., 1992; Ahmed and Gray, 1996;containing viral peptides to directly visualize antigen-
Zinkernagel et al., 1996). This has led to the hypothesisspecific CD8 T cells during acute LCMV infection of
that most of the CD8 T cell expansion is not antigenmice. Based on tetramer binding and two sensitive
specific and represents bystander activation and/orassays measuring interferon-g production at the sin-
cross-reactive stimulation of nonspecific cells. Experi-gle-cell level, we found that 50%±70% of the activated
mental evidence for cytokine-mediated bystander T cellCD8 T cells were LCMV specific (2 3 107 virus-specific
proliferation during viral infection has come from studiescells/spleen). Following viral clearance, antigen-spe-
by Tough et al. (1996), who showed that type 1 interfer-cific CD8 T cell numbers dropped to 106 per spleen
ons can induce proliferation of activated (CD44hi) CD8and were maintained at this level for the life of the
T cells and that this proliferation occurs independentlymouse. Upon rechallenge with LCMV, there was rapid
of signalingthrough theT cell receptor (TCR). Two recentexpansion of memory T cells, but after infection with
studies (Ehl et al., 1997; Zarozinski and Welsh, 1997)the heterologous vaccinia virus there was no detect-
have questioned the contribution of bystander activa-able change in the numbers of LCMV-specific memory
tion in viral infection, but the issue remains unresolvedCTL. Therefore, much of the CD8 T cell expansion seen
because the specificity of the majority of the respondingduring viral infection represents antigen-specific cells
T cells has not been defined.and warrants a revision of our current thinking on the
In this study we have reexamined the question ofsize of the antiviral response.
specificity. This is a critical issue because the current
models of T cell activation during viral infection areIntroduction
based on thenotion that most (.95%) of theproliferating
cells are nonspecific (Tough and Sprent, 1996; Tough etViral infections are often characterized by substantial
al., 1996). We used tetramers of major histocompatibilityactivation and expansion of CD8 T cells. This is seen in
(MHC) class I molecules containing viral peptides tohumans during the acute phase of infection with viruses
directly visualize antigen-specific CD8 T cells duringthat replicate systemically, such as human immunodefi-
acute LCMV infection. Based on tetramer binding andciency virus (HIV), Epstein-Barr virus (EBV), measles and
two sensitive functional assays to measure interferon-gcytomegalovirus (Koup et al., 1994; Pantaleo et al., 1994,
(IFNg) production at the single-cell level, we found that1997; Griffin, 1995; Callan et al., 1996; Oldstone, 1996;
at the peak of the primary and secondary responses,Wills et al., 1996; Borrow et al., 1997; Steven et al., 1997).
50%±70% of the activated CD8 T cells were LCMV spe-Expansions of CD8 T cells are also seen in experimental
cific. Thus, the size of the antiviral response is consider-models such as infection of mice with vaccinia virus
ably larger than our current estimates, and much of the(VV), vesicular stomatitis virus, murine g-herpesvirus,
expansion seen during viral infection represents expan-and lymphocytic choriomeningitis virus (LCMV) (Lau et
sion of antigen-specific T cells.al., 1994; Sunil-Chandra et al., 1994; Bi et al., 1995;
Cousens et al., 1995; Murata et al., 1996; Selin et al.,
1996; Doherty et al., 1997; Slifka et al., 1997). Because Results
of the potential for bystander activation to initiate
autoimmune reactions or to shape the memory T cell Size of the Primary Virus-Specific CD8
T Cell Response
Adult mice infected with LCMV (Armstrong strain) gener-³These two authors contributed equally to this work.
ate a potent immune response and clear the virus within§To whom correspondence should be addressed (email: ra@
microbio.emory.edu). 8±10 days. It is well established that clearance of this
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acute LCMV infection is mediated by CD8 CTL (Ahmed nominal antigenic peptide provide powerful reagents for
et al., 1984; Byrne et al., 1984; Moskophidis et al. 1987; quantitating antigen-specific CD8 T cells (Altman et al.,
Fung-Leung et al., 1991; Kagi et al., 1994; Walsh et al., 1996). This approach not only allows direct visualization
1994). The kinetics of the virus-specific CTL response of antigen-specific CD8 T cells, but also the analysis
and the expansion of CD8 T cells that occurs during the can be done on freshly explanted cells without any in
course of an acute LCMV infection have been exten- vitro manipulations. Tetramers of Ld containing NP118±
sively analyzed (Lau et al., 1994; Ahmed and Gray, 1996; 126 and Db containing NP396-404 or GP33-41 were used
Asano and Ahmed, 1996; Tough et al., 1996; Zimmerman to quantitate CD8 T cells specific for these epitopes.
et al., 1996). At the peak of the primary response, there Frequencies obtained by tetramer analysis were in the
is 10-fold or greater increase in the number of activated same range as those determined by the IFNg functional
CD8 T cells in thespleen and blood, and bromodeoxyuri- assays. A representative result is shown in Figure 2A:
dine (BrdU) labeling experiments have confirmed that 23% of CD8 T cells in LCMV-infected C57BL/6 mice
all of the activated (CD44hi) CD8 T cells undergo prolifer- (day 8) bound the MHC Db NP396-404 tetramer, and
ation. However, quantitation of CTL precursor (CTLp) 56% of CD8 T cells in infected BALB/c mice bound
frequencies by LDA has shown that only 1%±5% of the the Ld NP118±126 tetramer. There was minimal (,0.1%)
proliferating CD8 T cells are virus specific at the peak binding of these tetramers to CD8 T cells from naive
of the primary response (day 8 postinfection) (Moskoph- (uninfected) mice. Similar specific staining results were
idis et al., 1993; Nahill and Welsh, 1993; Lau et al., 1994; obtained with an Ld±immunoglobulin fusion protein
Andersson et al., 1995; Razvi et al., 1995; Borrow et al., loaded with the NP118-126 peptide that was produced
1996; Selin et al., 1996; Zinkernagel et al., 1996). We as described (Dal Porto et al., 1993) (data not shown).
have reexamined this issue using two sensitive func- By staining with tetramers in combination with BrdU
tional assays: intracellular staining for IFNg and single- labeling, it should be possible to determine the fraction
cell IFNg enzyme-linked immunospot (ELISPOT) assay. of antigen-specific CD8 T cells that have undergone
In addition, we have used tetramers of MHC class I proliferation during the 8-day period of infection. As
molecules bound to viral peptides to directly visualize shown in Figure 2B, all of the tetramer-positive cells
the antigen-specific CD8 T cells. (both Db NP396-404 specific and Db GP33-41 specific)
BALB/c (H-2d) and C57BL/6 (H-2b) mice were infected proliferated during LCMV infection. Although this is the
with LCMV, and at the peak of the primary response expected result, this analysis provides direct proof of
(day 8) the frequency of CD8 T cells specific for the turnover of antigen-specific CD8 T cells in vivo. BrdU
different LCMV CTL epitopes was determined by func- labeling experiments have been done previously with
tional assays. Spleen cells freshly explanted from in- transgenic T cells (Bruno et al., 1996; Pihlgren et al.,
fected mice were cultured in vitro (5 hr for intracellular 1996; Zimmerman et al., 1996), but our studies provide
cytokine stain and 36 hr for ELISPOT) either without documentation of in vivo proliferation of antigen-spe-
stimulation (i.e., no peptide) or with peptides represent- cific T cells in nontransgenic mice.
ing CTL epitopes defined in BALB/c and C57BL/6 mice To further confirm the specificity of the MHC class I
(van der Most et al., 1996, 1998). We found that the size tetramers, Db NP396-404 tetramer±positive and ±nega-
of the virus-specific response was remarkably high. As tive CD8 T cells from C57BL/6 mice (day 8 postinfection)
shown in Figure 1A, 70% of the CD8 T cells in C57BL/6 were sorted, and the two populations were tested for
mice were LCMV specific; the strongest response was peptide-specific lytic activity and for secretion of IFNg
to peptide NP396-404 (33% 6 7.3% of CD8 T cells), after stimulation with NP396-404 peptide. Based on the
followed by the responses to GP33-41 (25% 6 4.1% IFNg ELISPOT assay, almost 100% of the tetramer-posi-
of CD8 T cells), GP276-286 (6% 6 2.8% CD8 T cells),
tive cells were NP396-404 specific (Figure 3). This result
NP205±212 (5.6% 6 3% of CD8 T cells), and GP92-101
shows that all of the tetramer-binding cells could score
(0.8% 6 0.6% of CD8 T cells). In BALB/c mice, the single
in a functional assay and cross-validates both the physi-
immunodominant epitope NP118±126 constituted up to
cal (tetramer binding) and functional (IFNg production)50% (43% 6 7.4%) of the CD8 T cells. A representative
techniques we have used to quantitate antigen-specificset of the actual data along with specificity controls is
CD8 T cells.shown in Figure 1B. Spleen cells from LCMV-infected
The ability to kill peptide-coated targets was alsomice made no IFNg in the absence of stimulation, and
greatly enriched (.20 fold) in the sorted tetramer-posi-peptide-stimulated spleen cells did not show any intra-
tive CD8 T cell population (Figure 3). Even at the lowcellular staining above backgroundwith the isotype con-
effector:target ratio of 0.1:1, there was clearly observ-trol antibody, confirming the specificity of the intracellu-
able killing of peptide NP396-404±coated targets. Inlar IFNg stain. An NP118-stimulated sample is shown in
contrast, CD8 T cells that did not bind the Db NP396-Figure 1B; there were 0.4% positive cells with the iso-
404 tetramer (i.e., tetramer-negative cells) showed mini-type control antibody versus 52% positive cells with the
mal to no killing of NP 396-404±coated targets but wereIFNg-specific antibody. In addition, spleen cells from
able to kill GP33-41±coated targets. This further con-uninfected BALB/c mice did not produce any IFNg after
firmed the specificity of the Db NP396-404 tetramer bystimulation with any of the peptides (data not shown).
revealing that tetramer-binding cells were functionallyThe data in Figure 1C show that all of the NP396-404±
enriched for killing of NP396-404±coated targets andspecific CD8 T cells were CD44hi. Similar results were
that the tetramer-negative population contained few, ifseen with CD8 T cells responding to the other epitopes
any, cells that scored as NP396-404 specific by func-(data not shown).
Tetramers of MHC class I molecules containing the tional assays. Finally, the data in Figure 3 show that
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Figure 1. High Frequency of Virus-Specific CD8 T Cells during Primary LCMV Infection
(A) C57BL/6 and BALB/c mice were infected with LCMV, and 8 days later the frequency of specific CD8 T cells in the spleen was measured
by single-cell IFNg ELISPOT assay (open circles) or by intracellular IFNg staining (open triangles). Data are presented as the percentage of
CD8 T cells that make IFNg upon stimulation with each of the indicated CD8 epitopes. Each point represents an individual mouse, and the
filled circles represent the average values 6 SD for each epitope.
(B) Spleen cells from LCMV-infected (day 8) BALB/c and C57BL/6 mice were cultured in vitro for 5 hr either with or without the indicated
peptides and stained for intracellular IFNg. The numbers shown indicate the percentage of CD8 T cells that are positive for the intracellular
IFNg stain. Isotype control antibody for anti-IFNg was used routinely for all of the samples, and a representative analysis after NP118 stimulation
is shown in the upper right corner. Data are representative of six experiments.
(C) Spleen cells from LCMV-infected (day 8) C57BL/6 mice were cultured in vitro for 5 hr either with or without peptide NP396-404. Cells were
stained for surface CD8 and CD44 followed by intracellular IFNg. Cells were gated on a CD81 population and analyzed for surface CD44
versus intracellular IFNg stain. Numbers shown are the percentage of CD8 T cells that fall into the indicated quadrant.
MHC class I tetramers can be used to isolate a pure the various CTL epitopes in BALB/c and C57BL/6 mice
were quantitated for more than 1 yr after infection bypopulation of antigen-specific CD8 T cells.
Together, the results presented in Figures 1±3 show means of the two IFNg assays and MHC class I tetramer
binding. The results of these analyses are summarizedthat the majority (50%±70%) of activated CD8 T cells
are virus specific at the peak of the primary response in Figure 4.
In BALB/c mice, memory CD8 T cells specific for theto LCMV. This finding greatly revises our previous esti-
mates of the size of the antiviral T cell response. immunodominant NP118±126 epitope could be readily
detected at a remarkably high frequency of 1 in 10 CD8
T cells. In the sample shown in Figure 4C, 14% of theKinetics of the Primary Response and
Quantitation of Memory CD8 T Cells CD8 T cells were NP118±126 specific based on the intra-
cellular IFNg stain, and 13% were specific accordingThe CD8 T cell response to acute LCMV infection con-
sists of three distinct phases: (1) activation and expan- to Ld NP118±126 tetramer binding. Similar frequencies
were obtained by the ELISPOT assay (data not shown).sion (days 1±8 postinfection); (2) death (days 8±30), dur-
ing which more than 95% of the activated CD8 T cells Memory CD8 T cells specific for NP118±126 were main-
tained at these high frequencies for more than 1 yr. Indie by apoptosis; and (3) memory (after day 30), when
a stable pool of memory T cells persists for the life of fact, there was no change in either the total number
or the frequencies of NP118-126±specific CD8 T cellsthe mouse. The frequencies of memory CD8 T cells to
Immunity
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Figure 3. Isolation of a Pure Population of Antigen-Specific CD8 T
Cells by Sorting MHC Tetramer±Positive Cells
Spleen cells from LCMV-infected (day 8) C57BL/6 mice were double-
stained with anti-CD8 and tetramer Db NP396-404. Tetramer and
CD8 double-positive cells were sorted and assayed for single-cell
IFNg ELISPOT andex vivo CTL activity. In theELISPOT assay, sorted
tetramer-positive cells were plated at a graded density starting from
250 cells/well and cultured with or without peptide stimulation. The
data represent average values at each point and variation among
duplicates was less than 7%. The sorted tetramer positive cells did
not show any IFNg production upon stimulation with another Db-
restricted peptide, GP33-41. In the ex vivo CTL assay, sorted tetra-
mer-positive and tetramer-negative and unsorted total spleen cells
were assayed on 51Cr-labeled H-2b targets that were coated with
peptide NP396-404 (filled symbols) in a 5 hr 51Cr-release assay. No
lysis of uncoated targets was seen with any of the three effectors
(open squares). The purity of the sorted population was 99% for
tetramer-positive CD8 and 97% for tetramer-negative CD8. E:T, ef-Figure 2. Visualization of Virus-Specific CD8 T Cells by MHC Class
fector:target.I Tetramers Containing Viral Peptide
(A) Spleen cells from naive or LCMV-infected (day 8) C57BL/6 and
BALB/c mice were double-stained for surface CD8 and the indicated
MHC class I tetramer±peptide complex. Numbers show the percent- 1 in 30 CD8 T cells and for the weaker GP276-286 epi-
age of CD8 T cells that are tetramer positive. Data shown are repre-
tope 1 in 70 (Figure 4B). As in BALB/c mice, frequenciessentative of five such analyses.
for the three CTL epitopes were maintained over the(B) C57BL/6 mice were infected with LCMV and fed continuously
long term and equally well, with minimal fluctuation. Inwith BrdU-containing water for 8 days. On day 8 postinfection,
freshly explanted spleen cells were double-stained for surface CD8 addition, once again the size of the memory pool was
and the indicated tetramer±peptide complex followed by intracellu- a function of the burst size during the primary response.
lar staining for BrdU. Cells were gated on a CD81 population and After adding responses to all of the CTL epitopes, the
analyzed for tetramer and BrdU double-positive cells. Data are rep-
total number of LCMV-specific memory CD8 T cells inresentative of three similar experiments.
both BALB/c and C57BL/6 mice was in the range of 1 3
106/spleen (i.e., 10% of the total CD8 T cells).
The data in Figures 4C and 4D also demonstrate that
memory T cells can respond very rapidly to restimulationbetween day 30 and day 400 postinfection (Figure 4A).
A similar pattern was seen with the subdominant Kd- with peptide. In these assays, freshly explanted memory
CD8 T cells were stimulated for only 5 hr with peptiderestricted CTL epitope GP283-291, showing that long-
term memory was equally well maintained for weak as prior to staining for IFNg. As is evident from the fluores-
cence-activated cell sorter (FACS) analysis, memory Twell as strong epitopes. It is worth emphasizing that the
number of NP 118-126± and GP283-291±specific CD8 cells were capable of making considerable amounts of
cytokine in this short period. No IFNg was made in theT cells present in the memory pool was determined
almost exclusively by the original burst size. There were absence of peptide (data not shown). It is also worth
noting that this state of quick responsiveness was main-approximately 20 x 106 NP118±126-specific CD8 T cells
on day 8, and about 5% (1 3 106) of these cells survived tained for extended periods; the samples shown in Fig-
ure 4C and 4D were taken from immune mice 240 andto go into the memory pool. The same trend was seen
with the GP283-291 response: at the peak there were 270 days after infection.
The frequencies of virus-specific CD8 T cells obtainedapproximately 1 3 106 specific CD8 T cells, and immune
mice contained 5 3 104 GP283-specific memory CD8 T by the two IFNg assays (intracellular stain and ELISPOT)
and the MHC class I tetramer reagents were, for thecells (i.e., 5% of the primary response). In C57BL/6 mice,
frequencies of memory CD8 T cells for the two dominant most part, in general agreement with each other (Figures
1±4). However, these values were substantially higherepitopes (NP396-404 and GP33-41) were approximately
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Figure 4. Quantitation and Visualization of Antigen-Specific Memory CD8 T Cells during LCMV Infection
BALB/c (A) and C57BL/6 (B) mice were checked at the indicated days postinfection for the number of virus-specific CD8 T cells in the spleen
by IFNg single-cell assays and MHC class I tetramer staining. Data represent average values obtained from three to five mice at each time
point. The frequencies of peptide-specific cells/total CD8 T cells are indicated for each of the epitopes at selected time points. On day 3, the
frequencies for NP118 were 1 in 1000 and for GP283, 1 in 10,000; on day 5, the frequencies were 1 in 4 for NP118 and 1 in 30 for GP283. In
C57BL/6 mice the day 5 frequencies were 1 in 12 for NP396, 1 in 27 for GP33, and 1 in 180 for GP276. On day 0 postinfection the number of
peptide-specific CD8 T cells was below detection (dotted line).
(C) Spleen cells from LCMV-infected BALB/c mice 240 days postinfection were incubated with peptide NP118±126 for 5 hr, followed by
staining for surface CD8 and intracellular IFNg. Antigen-specific cells from the same mouse were visualized by staining freshly explanted
spleen cells with LdNP118±126 tetramer.
(D) C57BL/6 mice 270 days postinfection were incubated in the presence of the indicated peptides followed by intracellular IFNg staining, or
freshly explanted spleen cells were stained with the indicated MHC tetramer±peptide complexes. Numbers represent the percentage of CD8
T cells that are antigen specific.
than published data on LCMV-specific CTLp frequencies among the three epitopes analyzed, the weaker epitope
(GP276-286) showed the largest disparity in frequenciesbased on LDA. To compare these techniques directly,
we quantitated CD8 T cells specific for different LCMV obtained by the two techniques.
epitopes by LDA and IFNg ELISPOT assay in acutely
infected (day 8) and immune (day 120) C57BL/6 mice Doubling Time of Antigen-Specific CD8 T Cells
The doubling time of virus-specific CD8 T cells during(Table 1). On day 8 postinfection, frequencies obtained
by ELISPOT were 20- to 100-fold higher than precursor the expansion phase (days 1±8 postinfection) can be
calculated from the data in Figure 4. The frequencies offrequencies from LDA. In immune mice the differences
were less, but ELISPOT numbers were still 10- to 20- CD8 T cells specific for a given epitope in naive mice
are probably in the range of 1024± 1025 per CD8 T cells,fold higher than LDA numbers. It is noteworthy that
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Table 1. Quantitation of LCMV-Specific CD8 T Cells by LDA for CTLp and IFNg ELISPOT
Antigen-Specific CD8 T Cell Frequency
LCMV Infection Peptide Mouse LDA for CTLp IFNg ELISPOT ELISPOT/LDA Ratio
8 days (acute) NP396-404 1 1/122 1/4.9 25
2 1/76 1/4.8 16
3 1/162 1/4.0 40
GP33-41 1 1/81 1/3.5 23
2 1/152 1/7.1 21
3 1/270 1/4.1 65
GP276-286 1 1/818 1/22 37
2 1/1900 1/19 100
3 1/2700 1/14.9 180
120 days (memory) NP396-404 1 1/420 1/35 12
2 1/350 1/27.5 13
3 1/400 1/34 12
GP33-41 1 1/700 1/50 14
2 1/500 1/31 16
3 1/420 1/33 13
GP276-286 1 1/2800 1/130 21
2 1/1800 1/115 16
3 1/2700 1/112 24
C57BL/6 mice were infected with LCMV (Armstrong) and the frequency of epitope-specific CD8 T cells in the spleen quantitated by LDA and
IFNg ELISPOT assay.
giving a baseline value of 102±103 epitope-specific CD8 GP283-specific CD8 T cells, suggesting that either these
T cells/spleen. Since this is a ªsoftº number, we have cells were present at a lower frequency in naive mice
not used it in calculating the doubling time of antigen- and/or that the concentration of GP283 peptide was
specific CD8 T cells. However, the values obtained on limiting during the early stages of infection. However,
days 3, 5, and 8 postinfection are based on highly spe- between days 3 and 5, CD8 T cells responding to NP118
cific and sensitive assays and should allow us to deter- or GP283 expanded at similar rates (doubling time 6±8
mine the number of divisions virus-specific CD8 T cells hr), implying that neither epitope was limiting during this
have undergone during this 5-day period of antigen- period. After day 5, there was only minimal expansion
driven expansion. It should be pointed out that the in- of the subdominant response, suggesting that stimulus
crease in LCMV-specific CD8 T cells in the spleen truly from the weaker epitope was considerably less than
represents cell proliferation and is not due simply to the dominant NP118 epitope. This simple model of viral
redistribution of T cells (i.e., migration of CD8 T cells to peptide concentration driving T cell expansion is consis-
spleen). As shown in Figure 2B, all of the antigen-specific tent with the kinetics of LCMV infection and the much
CD8 T cells in the spleen were BrdU positive. Moreover, higher binding affinity of the dominant NP 118 epitope to
during the acute phase of LCMV infection, not only was Ld compared with the binding of GP283 to its presenting
there an increase in the number of virus-specific CD8 T molecule Kd (IC50 [concentration of peptide inhibiting
cells in the spleen, but similar expansions were seen in 50% of the binding of the radiolabeled probe]: 1.3 nM
the blood and lymph nodes (data not shown). Thus, the for NP118 vs. 73 nM for GP283) (van der Most et al.,
increase in antigen-specific CD8 T cells in the spleen 1996).
should reflect the division of these cells. As shown in
Figure 4A, on day 3 after LCMV infection there were
Effect of Homologous and Heterologous Virus1.2 6 0.3 3 104 NP118-126±specific CD8 T cells/spleen;
Infection on LCMV-Specific Memoryby day 5 the number had increased to 4 6 1.0 3 106;
CD8 T Cellsand by day 8 the number had reached a peak of 2.8 6
We next examined theeffect of homologous and heterol-1.0 3 107. This represented a 2300-fold increase (z11
ogous virus infections on the frequency and effectordivisions) in 5 days, with the fastest growth occurring
function (killing) of LCMV-specific memory CD8 T cells.between days 3 and 5, during which period NP118±126-
LCMV immune mice were divided into three groups: onespecific CD8 T cells increased about 500-fold (9 divi-
group was left untreated; the second group was infectedsions) with an estimated doubling time of 6±8 hr. Although
with VV; and the third group was rechallenged withthe number of antigen-specific CD8 T cells continued
LCMV. Seven days after infection, the frequency ofto increase between days 5 and 8, there was a consider-
LCMV-specific CD8 T cells and the presence of LCMV-able slowing of the growth rate (2 or 3 divisions with an
specific and VV-specific CTL activity were determined.estimated doubling time of 24±30 hours), and this slow
The results of a representative experiment (one of three)growth coincided with clearance of the virus (Lau et al.,
are shown in Figure 5. Rechallenge with homologous1994; Asano and Ahmed, 1996).
virus stimulated proliferation of LCMV-specific CD8 TIt is useful to compare the expansion kinetics of the
cells and the development of virus-specific killer cells.dominant NP 118 response with the weaker GP283 re-
sponse (Figure 4A). On day 3, there were 10-fold fewer In contrast, immune mice infected with VV did not show
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GP33-, and GP276-specific CD8 T cells was monitored
by tetramer staining and functional assays on days 3
and 5 post infection. Identification of NP396-specific
CD8 T cells by Db NP396 tetramers is shown in Figure
6A; Figure 6B presents a summary of data on all three
epitopes. As shown in Figure 6A, there was rapid expan-
sion of NP396-specific CD8 T cells after LCMV infection.
Within 3 days, 38% of CD8 T cells were NP396 specific,
and by day 5 this population had increased to 46%. By
gating on Db NP396 tetramer±positive cells and looking
at the forward scatter (size), we found that more than
60% of the NP396-specific CD8 T cells were blasting
on day 3 after infection, documenting the rapid recall
response of memory T cells. This blasting population
had decreased by day 5, consistent with data showing
that immune mice resolve LCMV infection within 5 days
(Lau et al., 1994). During the secondary in vivo response,
the largest expansion was seen in NP396-specific CD8
T cells, followed by GP33 and GP276. When responses
to all the epitopes were added together, more than 70%
of the total CD8 T cells were LCMV specific on day 5
after rechallenge. Similar results were obtained when
immune mice were rechallenged with LCMV Armstrong
(data not shown). Thus, as in the primary infection, most
of the CD8 T cell expansion during the recall response
represents antigen-specific CD8 T cells.
Figure 5. Expansion of Memory CD8 T Cells by Homologous but Discussion
Not by Heterologous Virus Challenge
(A) LCMV-immune C57BL/6 or BALB/c mice 6 months postinfection
The mainpoint of this study is that the size of the antiviralwere either untreated (no challenge), infected with VV, or infected
response is much greater than our previous estimateswith LCMV clone 13. On day 7 postinfection, spleen cells from indi-
and that as many as 70% of the responding CD8 T cellsvidual mice were assayed for the number of antigen-specific CD8 T
cells. The antigen-specific cell number was quantitated by tetramer during both primary and secondary infection can be
staining and ELISPOT assay. Each point represents an individual virus specific. This finding, along with the results show-
mouse. ing that a heterologous virus infection does not increase
(B) Spleen cells from LCMV-immune C57BL/6 or BALB/c mice that
the number of memory T cells to an unrelated virus,were mock infected, VV infected, or LCMV clone 13 infected as
provide compelling evidence that most of the CD8 T celldescribed in (A) were tested for their ex vivoCTL activity on indicated
expansion seen during viral infection represents anti-targets. The targets used were H-2b targets (in the case of C57BL/6
mice) or H-2d targets (in the case of BALB/c mice) that were either gen-specific T cells. This should lead to a revision of
uninfected, VV infected, or LCMV infected. our current models of viral-induced T cell proliferation
that are based on the notion that most of the responding
T cells are not specific to the infecting virus.
Why have previous studies underestimated the sizeany detectable increase in the numbers of LCMV-spe-
cific memory CD8 T cells (Figure 5A). The VV-infected of the virus-specific T cell response? In almost all viral
systems examined to date, the LDA has been used tomice had enlarged spleens and lymph nodes and con-
tained 20±40 3 106 CD8 CD44hi cells/spleen compared quantitate virus-specific CTLp (Doherty et al., 1992;
Ahmed and Gray., 1996; Zinkernagel et al., 1996). Thisto 5 3 106 in untreated immune mice. Thus, despite a
substantial increase in the total number of activated technique involves plating graded numbers of cells in
96-well plates and stimulating them for 1±2 weeks inCD8 Tcells, there was minimal to noexpansion of LCMV-
specific CD8 T cells. However, spleen cells from VV- the presence of antigen plus interleukin-2 (IL-2). At the
end of the culture period the contents of each well arechallenged LCMV immune mice exhibited a higher level
of direct ex vivo LCMV-specific CTL activity compared tested for the presence of antigen-specific killer cells.
An important caveat of this widely used assay is thatto untreated immune mice (Figure 5B). The level of killing
was about 3- to 5-fold higher based on lytic units. Taken only cells that are capable of dividing and surviving
during the 1- to 2-week in vitro culture period will scoretogether, these results showthat infection with a heterol-
ogous virus does not increase the total number of LCMV- as positive. Several recent studies have shown that acti-
vated T cells are prone to apoptosis upon restimulationspecific memory T cells but does induce killing function
in this population of memory T cells. with antigenÐa phenomenon termed activation-induced
cell death (AICD) (Nagata and Golstein, 1995). Thus, itThe in vivo recall response after challenge with homol-
ogous virus was examined in more detail. LCMV-immune is likely that many antigen-specific T cells either die or
do not divide to a sufficient extent to score as positiveC57BL/6 mice were rechallenged with LCMV clone 13
(a variant of Armstrong), and the expansion of NP396-, in the LDA assay. In contrast, the techniques we have
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Figure 6. The Kinetics of LCMV-Specific CD8 T Cell Recall Responses
(A) C57BL/6 mice were immunized intraperitoneally with 2 3 105 pfu LCMV-Armstrong and rested 6 months prior to intravenous rechallenge
with 2 3 106 pfu of LCMV clone 13. Splenocytes from rechallenged mice were analyzed 3 or 5 days later as indicated. (Left) Frequencies of
NP396-404±specific cells per CD81CD44hi cells as determined by staining with Db NP396-404 tetramers. (Right) The forward scatter of antigen-
specific CD8 T cells (Db NP396 tetramer±positive) cells. Gates for the blasting population were based on the forward scatter profile of the
immune sample.
(B) Exponential division of memory CD8 T cells upon secondary rechallenge. LCMV immune C57BL/6 mice were rechallenged with LCMV
clone 13 as described in (A). Antigen-specific CD8 T cell numbers specific for each of the indicated immunodominant epitope were quantitated
using a single-cell IFNg ELISPOT assay.
used do not have this limitation. This is especially true Can our findings with the LCMV model be generalized
to other viral infections, including those by humanof staining with MHC class I tetramers, a method that
involves no in vitro manipulations and allows direct visu- pathogens? It has been known for many years that acute
EBV infection (infectious mononucleosis) is character-alization of the antigen-specific T cells. The two IFNg
functional assays require only a short period of in vitro ized by a massive increase in the number of CD8 T cells
(Callan et al., 1996), and more recently it has also beenstimulation (5 hr for intracellular stain and 24±36 hr for
ELISPOT), and neither technique is dependent on long- shown that substantial CD8 T cell expansion occurs
during primary HIV infection (Koup et al., 1994; Pantaleoterm cell survival or proliferation.
Analysis of LCMV-specific CD8 T cells in acutely in- et al., 1994, 1997). Increased numbers of activated CD8
T cells in the blood and cerebrospinal fluid of patientsfected mice (day 8) showed that frequencies obtained
by ELISPOT assay were 20- to 100-fold higher than infected with human T cell leukemia virus type 1 (HTLV-1)
have also been reported (Utz et al., 1996). It is likelynumbers based on LDA (Table 1). At this time (i.e., day
8 postinfection) there is a large number of effector CD8 that, similar to our findings with LCMV, the majority of
the expanded CD8 T cells are EBV, HTLV-1, and HIVCTL, and it is likely that a substantial fraction of these
highly activated cells are sensitive to AICD. Thus, it is specific. In fact, recent studies analyzing TCR usage by
CD8 T cells during acute EBV and HIV infections havenot surprising that LDA analysis underestimated the true
frequency of antigen-specific effector CD8 T cells. Al- shown expansions of a few dominant clones (Pantaleo
et al., 1994, 1997; Callan et al., 1996). Such oligoclonalthough fewer differences were seen with memory CD8
T cells, it is notable that even in immune mice, which populations are most consistent with antigen-driven
expansion of T cells. It will be interesting to see whathave very low if any effector CD8 T cells, only 10% of
the LCMV-specific cells scored as positive by the LDA frequencies are obtained in these human viral infections
using the techniques we have described in this study.technique. Similar results have recently been reported
for influenza virus (Lalvani et al., 1997). Thus, the LDA Even with viral infections that provide a much weaker
stimulus to CD8 T cells, such as herpes simplex virusappears to underestimate the true frequency of both
effector and memory T cells, with a greater underesti- (HSV), it is possible that most of the responding cells
are virus specific. A recent study (Cose et al., 1997)mate for effector T cells. In addition to differences due
to AICD, it is also possible that all virus-specific CD8 T analyzing CD8 T cell responses in lymph nodes draining
the site of HSV infection has documented expansion ofcells can secrete IFNg but only a subset of these cells
can differentiate into killer cells. CD8 T cells expressing a restricted TCR, suggesting
Counting Antigen-Specific T Cells
185
Experimental Proceduresthat a large proportion of the blasting cells may be HSV
specific. Thus, it is likely that our study in the LCMV
Virus Infection and Micesystem, showing that more than 70% of the responding Six- to 8-week-old male or female BALB/c and C57BL/6 mice were
CD8 T cells are virus specific, will become a paradigm purchased from the Jackson Laboratories (Bar Harbor, ME). Mice
for viral infections in general. were infected with 2 3 105 pfu of LCMV Armstrong intraperitoneally
and used at the indicated time points. For secondary rechallengeIt is well established that following viral clearance
experiments, immune mice were injected with 2 3 106 pfu of LCMVthere is a precipitous drop in the number of antigen-
clone 13 intravenously or with 2 3 106 pfu of VV intraperitoneally.specific CD8 T cells (Ahmed and Gray, 1996). During
Virus stocks were grown and quantitated as described previously
this period of death, more than 90% of the activated T (Ahmed et al., 1984).
cells undergo apoptosis. This down-regulation of the
immune response is necessary to maintain homeosta- Single-Cell ELISPOT Assay for IFNg-Secreting Cells
The ELISPOT assay described by Taguchi et al. (1990) was modifiedsis. In this study we have extended these findings to
to detect virus-specific CD8 T cells. First, 96-well filtration platesCD8 T cells responding to individual epitopes and have
(Millipore, Bedford, MA) were coated with rat anti-mouse IFNg anti-asked whether the contraction of the response is similar
body (clone R4±6A2, Pharmingen, San Diego, CA). Three- or 2-fold
for dominant and subdominant epitopes. We found that dilutions of responder cells in RPMI 1640 medium supplemented
the proportion of activated CD8 T cells that died was with 10% fetal calfserum, 4 mM L-glutamine, 50 mM 2-mercaptoeth-
almost identical for dominant (NP118 in BALB/c; NP396 anol, and antibiotics (complete medium) were added into the wells
along with 5 3 105 g-irradiated (1200 rad) syngenic feeder cells andand GP33 in C57BL/6 mice) and subdominant (GP283
10 units/well of recombinant human IL-2 (Pharmingen). Cells werein BALB/c, GP276 in C57BL/6) responses. For each of
incubated for 36 hr either with or without peptide stimulation (0.1the peptide-specific responses, approximately 5% of
mg peptide/ml). The amino acid sequences of peptides used have
the activated CD8 T cells survived and went into the been described (van der Most et al., 1996, 1998). After culture, the
pool of memory T cells, and then long-term memory plates were washed followed by incubation with biotinylated anti-
mouse IFNg antibody (clone XMG 1.2, Pharmingen). Spots werewas equally well maintained for both strong and weak
developed using freshly prepared substrate buffer (0.3 mg/ml ofepitopes. Together these results show that the differ-
3-amino-9-ethyl-carbazole and 0.015% H202 in 0.1 M sodium acetateence between a strong response and a weak response
[pH 5]). The frequencyof peptide-specific CD8 Tcells was calculated
was not in the death phase nor in the maintenance of based on the percentage of CD8 T cells present in the responding
memory but was determined by the original burst size. population. Using this assay we could accurately measure a mini-
These findings have clear implications for developing mum of ten spots in 106 responder cells.
strategies to improve vaccines. They show that the size
Flow Cytometry and FACS Analysisof the memory T cell pool is determined by the original
Single-cell suspensions of spleen were prepared, and 106 cells wereburst size and emphasize the importance of initial prim-
stained in phosphate-buffered saline containing 1% bovine serum
ing in inducing long-term immunity. albumin and 0.02% sodium azide (FACS buffer) for 30 minutes at 48C
We found that infection of LCMV immune mice with VV followed by three washes in FACS buffer. Samples were acquired on
did not result in any detectable changes in the number either a FACScan flow cytometer orFACSCalibur instrument (Becton
Dickinson, San Jose, CA). The data were analyzed using CELLQuestof LCMV-specific memory T cells despite a substantial
software (Becton Dickinson Immunocytometry Systems).increase in the total number of activated CD8 T cells.
In fact, as a result of this VV-driven expansion of non±
Intracellular IFNg Staining
LCMV-specific CD8 T cells, the frequency of LCMV- Spleen cells were cultured for 5 hr in 96-well flat-bottomed plates
specific CD8 T cells was 2- to 3-fold lower at the peak (Costar, Cambridge, MA) at a concentration of 1 3 106 cells/well in
of the VV response (day 7 postinfection). This shows a volume of 0.2 ml complete medium supplemented with 10 units/
well human recombinant IL-2 and 1 ml/ml Brefeldin A (Golgistop,that bystander activation plays a minimal role in the
Pharmingen) either with or without CTL epitope peptides. The pep-CD8 T cell expansion observed during viral infections.
tides were used at a concentration of 0.1 mg/ml. After 5 hr of culture,However, LCMV immune mice showed increased levels
the cells were harvested, washed once in FACS buffer, and surface
of LCMV-specific CTL activity after VV infection. Similar stained in FACS buffer with phycoerythrin (PE)-conjugated mono-
findings have been reported by others (Selin et al., 1996; clonal rat anti mouse CD8a (clone 53±6.7) antibody. After washing
the unbound antibody, cells were subjected to intracellular cytokineEhl et al., 1997). It is unlikely that this increased killing is
stain using the Cytofix/Cytoperm kit according to themanufacturer'sdue to VV-specific CTL that are cross-reactive to LCMV
instructions (Pharmingen). For intracellular IFNg staining we usedbecause naive mice infected with VV do not exhibit any
FITC-conjugated monoclonal rat anti-mouse IFNg antibody (clone
detectable killing of LCMV-infected targets. So it ap- XMG 1.2) and its isotype control antibody (rat IgG1) (Pharmingen).
pears that infection with a heterologous virus does not
increase overall numbers of LCMV-specific CD8 T cells Preparation of H-2Db and H-2Ld Tetramers
The expression cassette for fusions to a BirA substrate peptidebut increases the level of cytotoxicity. This effect could
(BSP) (Schatz, 1993) was moved from pHN1-A2-BSP (Altman et al.,be mediated by cytokines (IL-12, for example) and/or
1996) on a SacI±Hind III fragment (containing the a3 domain of A2could be due to a low-affinity TCR interaction that does
plus the BSP) that was subcloned into the T7 polymerase vector
not induce proliferation but causes differentiation of a pET-23a(1) (Novagen) cut with the same enzymes to create pET-
subset of memory cells into killer cells. 23a-BSP. DNA coding for residues 1±280 of the soluble domain of
Db was amplified (from a Db plasmid clone [a generous gift from S.In conclusion, this study provides definitive evidence
Nathenson]) by the PCR with the 59 primer GGGAATTCATATGGGCCthat the majority of the CD8 T cells responding to a viral
CACACTCGATGCGG and the 39 primer CGGGATCCGGACGGAGGAinfection are antigen specific. This greatly revises our
GGCTCCCA. This fragment was cut with NdeI and BamHI (sites
current thinking on the dynamics of T cell activation underlined) and subcloned into pET-23a-BSP cut with the same
in vivo and warrants a reexamination of the prevailing enzymes (removing the a3 domain of A2) to create the plasmid
pET23-Db-BSP. Similarly, DNA coding for residues 1±280 of the Ldmodels of viral-induced T cell proliferation.
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was amplified (from a plasmid clone [a generous gift from Y. H. Andersson, E.C., Christensen, J.P., Scheynius, A., Marker, O., and
Thomsen, A.R. (1995). Lymphocytic choriomeningitis virus infectionChien]) with the 59 primer GGAATTCCATATGGGCCCACACTCGATG
is associated with long-standing perturbation of LFA-1 expressionCGG and the 39 primer as above and identically subcloned to create
on CD81 T cells. Scand. J. Immunol. 42, 110±118.pET23-Ld-BSP. The sequences of the MHC genes for both plasmids
were verified by standard dideoxysequencing. Each clone was used Asano, M.S., and Ahmed, R. (1996). CD8 T cell memory in B cell-
to transform the Escherichia coli strain BL21(DE3) and expression deficient mice. J. Exp. Med. 183, 2165±2174.
was induced with isopropyl-b-D-thiogalactopyranoside as de- Beverley, P.C. (1990). Is T-cell memory maintained by crossreactive
scribed (Altman et al., 1993). Human b2-microglobulin (b2m) was stimulation? Immunol. Today 11, 203±205.
expressed from the plasmid pHN1-b2m as described (Garboczi et al.,
Bi, Z., Barna, M., Komatsu, T., and Reiss, C.S. (1995). Vesicular1992). Folding, purification, biotinylation, and tetramer production of
stomatitis virus infection of the central nervous system activatesLd and Db peptide complexes was performed as described (Altman
both innate and acquired immunity. J. Virol. 69, 6466±6472.et al., 1996).
Borrow, P., Tishon, A., Lee, S., Xu, J., Grewal, I.S., Oldstone, M.B.,
and Flavell, R.A. (1996). CD40L-deficient mice showdeficits in antivi-BrdU Staining
ral immunity and have an impaired memory CD81 CTL response.For BrdU labeling,LCMV (Armstrong)±infected mice were fed contin-
J. Exp. Med. 183, 2129±2142.uously with drinking water containing BrdU (0.8 mg/ml) for 8 days.
Borrow, P., Lewicki, H., Wei, X., Horwitz, M.S., Peffer, N., Meyers,On day 8 postinfection, freshly explanted spleen cells were surface
H., Nelson, J.A., Gairin, J.E., Hahn, B.H., Oldstone, M.B., and Shaw,stained with PE-conjugated anti-mouse CD8, Cychrome-conjugated
G.M. (1997). Antiviral pressure exerted by HIV-1-specific cytotoxicanti-mouse CD44 (Pharmingen), and allophycocyanin-conjugated
T lymphocytes (CTLs) during primary infection demonstrated byMHC tetramer of indicated specificity followed by intracellular BrdU
rapid selection of CTL escape virus. Nature Med. 3, 205±211.stain as described (Tough and Sprent, 1994). For BrdU staining,
FITC-conjugated mouse anti-BrdU antibody (Clone B44, Becton Bruno, L., von Boehmer, H., and Kirberg, J. (1996). Cell division
in the compartment of naive and memory T lymphocytes. Eur. J.Dickinson) or its isotype control (mouse IgG1 antibody) were used.
Immunol. 26, 3179±3184.
Sorting of MHC Tetramer±Positive Cells Byrne, J.A., Ahmed, R., and Oldstone, M.B. (1984). Biology of cloned
Freshly explanted spleen cells from LCMV-infected mice (day 8 cytotoxic T lymphocytes specific for lymphocytic choriomeningitis
postinfection) were surface stained with PE-conjugated anti-CD8 virus: I. generation and recognition of virus strains and H-2b mutants.
antibody and allophycocyanin-conjugated Db NP396-404 tetramer J. Immunol. 133, 433±439.
in RPMI 1640 medium containing 1% fetal calf serum. CD8 T cells Callan, M.F., Steven, N., Krausa, P., Wilson, J.D., Moss, P.A., Gilles-
were sorted into tetramer-positive and -negative poulations in a pie, G.M., Bell, J.I., Rickinson, A.B., and McMichael, A.J. (1996).
Becton Dickinson FACS sorter. Large clonal expansions of CD81 T cells in acute infectious mono-
nucleosis. Nature Med. 2, 906±911.
Ex Vivo CTL Assay and LDA Cao, W., Tykodi, S.S., Esser, M.T., Braciale, V.L., and Braciale, T.J.
Cytotoxic activity was tested in a standard 6 hr 51Cr release assay (1995). Partial activation of CD81 T cells by a self-derived peptide.
as described previously. For VV infection, targets were infected at Nature 378, 295±298.
a multiplicity of infection of 10. Targets were coated with peptide
Cose, S.C., Jones, C.M., Wallace, M.E., Heath, W.R., and Carbone,NP396-404 or GP33-41 at a concentration of 0.1 mg/ml. LDA was
F.R. (1997). Antigen-specific CD81 T cell subset distribution in
performed as described previously (Lau et al., 1994; van der Most
lymph nodes draining the site of herpes simplex virus infection. Eur.
et al., 1996).
J. Immunol. 27, 2310±2316.
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